Chengyao Wu
Anhui Province Key Laboratory Of Major Autoimmune Diseases
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Thymol carbamates bearing cyclic amines as potent and selective BuChE inhibitors alleviate memory impairments for Alzheimer's disease therapy.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 06, 2026
Structure-Tissue Exposure/Selectivity Relationship (STR) on Carbamates of Cannabidiol.
Journal: International journal of molecular sciences
Published: October 21, 2024
Microtiter plate-based chemistry and in situ screening: SuFEx-enabled lead discovery of selective AChE inhibitors.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: July 28, 2023
Sulfur-fluoride exchange (SuFEx)-enabled lead discovery of AChE inhibitors by fragment linking strategies.
Journal: European journal of medicinal chemistry
Published: April 04, 2023
Fluorosulfate-containing pyrazole heterocycles as selective BuChE inhibitors: structure-activity relationship and biological evaluation for the treatment of Alzheimer's disease.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: July 28, 2022
Novel benzothiazole‒urea hybrids: Design, synthesis and biological activity as potent anti-bacterial agents against MRSA.
Journal: European journal of medicinal chemistry
Published: January 27, 2022
Structure-activity relationship, in vitro and in vivo evaluation of novel dienyl sulphonyl fluorides as selective BuChE inhibitors for the treatment of Alzheimer's disease.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: August 24, 2021
Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: June 15, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026